PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35314480-10	2022	During hydrochlorothiazide treatment, plasma copeptin (surrogate for vasopressin) decreased, quality of life improved, and several markers of kidney damage and glucose metabolism improved.	Hydrochlorothiazide	7-26	arginine vasopressin	Homo sapiens	45-53	
2274021-2	1990	In patients with reduced circulating levels of vasopressin, chlorpropamide, clofibrate, idroclorotiazide etc., enhance the effect of vasopressin on the renal tubule or induce a release of vasopressin, thus reducing the diuresis.	Hydrochlorothiazide	88-104	arginine vasopressin	Homo sapiens	47-58	
2274021-2	1990	In patients with reduced circulating levels of vasopressin, chlorpropamide, clofibrate, idroclorotiazide etc., enhance the effect of vasopressin on the renal tubule or induce a release of vasopressin, thus reducing the diuresis.	Hydrochlorothiazide	88-104	arginine vasopressin	Homo sapiens	133-144	
2274021-2	1990	In patients with reduced circulating levels of vasopressin, chlorpropamide, clofibrate, idroclorotiazide etc., enhance the effect of vasopressin on the renal tubule or induce a release of vasopressin, thus reducing the diuresis.	Hydrochlorothiazide	88-104	arginine vasopressin	Homo sapiens	133-144	
35314480-10	2022	During hydrochlorothiazide treatment, plasma copeptin (surrogate for vasopressin) decreased, quality of life improved, and several markers of kidney damage and glucose metabolism improved.	Hydrochlorothiazide	7-26	arginine vasopressin	Homo sapiens	69-80	
13997901-0	1962	[Inbitition of vasopressin antidiures is by hydrochlorothiazide].	Hydrochlorothiazide	44-63	arginine vasopressin	Homo sapiens	15-26	
6280212-1	1982	The effects of diazoxide and hydrochlorothiazide on vasopressin-induced increments in osmotic water flow and sodium transport across the frog bladder were studied.	Hydrochlorothiazide	29-48	arginine vasopressin	Homo sapiens	52-63	
34020248-8	2021	Our data show that tritherapy with firibastat, enalapril and HCTZ improves BP control and arginine-vasopressin release in an experimental salt-dependent model of hypertension, paving the way for the development of new treatments for patients with currently difficult-to-treat or resistant hypertension.	Hydrochlorothiazide	61-65	arginine vasopressin	Homo sapiens	99-110